Loading clinical trials...
Loading clinical trials...
This study will be investigating the effect of latent tuberculosis infection (LTBI) treatment on glucose tolerance and low-grade inflammation. Almost a century ago, researchers proposed that diabetes ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Herlev and Gentofte Hospital
NCT07590193 · Diabetes Mellitus, Type 2
NCT01212003 · Mycobacterium Infections, Tuberculosis, Multidrug-Resistant, and more
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT02861781 · Obesity, Insulin Resistance, and more
NCT03474029 · Latent Tuberculosis
Herlev-Gentofte Hospital
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions